Literature DB >> 18174459

Metabolic syndrome pandemic.

Scott M Grundy1.   

Abstract

The metabolic syndrome is a multiplex risk factor that consists of several risk correlates of metabolic origin. In addition, to dyslipidemia, hypertension, and hyperglycermia, the syndrome carries a prothrombotic state and a proinflammatory state. Persons with the metabolic syndrome are at essentially twice the risk for cardiovascular disease compared with those without the syndrome. It further raises the risk for type 2 diabetes by about 5-fold. Although some investigators favor keeping risk factors separate for purposes of clinical management, others believe that identifying individuals with an aggregation of risk factors provides additional useful information to guide clinical management. In particular it focuses attention on obesity and sedentary life habits that are the root of the syndrome. This review addresses the prevalence of this clustering phenomenon throughout the world. Such seems appropriate because of the increasing prevalence of obesity in almost all countries. The available evidence indicates that in most countries between 20% and 30% of the adult population can be characterized as having the metabolic syndrome. In some populations or segments of the population, the prevalence is even higher. On the other hand, in parts of developing world in which young adults predominate, the prevalence is lower; but with increasing affluence and aging of the population, the prevalence undoubtedly with rise.

Entities:  

Mesh:

Year:  2008        PMID: 18174459     DOI: 10.1161/ATVBAHA.107.151092

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  464 in total

1.  Association between organic food consumption and metabolic syndrome: cross-sectional results from the NutriNet-Santé study.

Authors:  Julia Baudry; Hélène Lelong; Solia Adriouch; Chantal Julia; Benjamin Allès; Serge Hercberg; Mathilde Touvier; Denis Lairon; Pilar Galan; Emmanuelle Kesse-Guyot
Journal:  Eur J Nutr       Date:  2017-08-02       Impact factor: 5.614

2.  Metabolic syndrome is associated with exposure to organochlorine pesticides in Anniston, AL, United States.

Authors:  Paula F Rosenbaum; Ruth S Weinstock; Allen E Silverstone; Andreas Sjödin; Marian Pavuk
Journal:  Environ Int       Date:  2017-08-02       Impact factor: 9.621

3.  Postnatal rosiglitazone administration to neonatal rat pups does not alter the young adult metabolic phenotype.

Authors:  Nghia C Truong; Afshan Abbasi; Reiko Sakurai; W N Paul Lee; John S Torday; Virender K Rehan
Journal:  Neonatology       Date:  2011-11-10       Impact factor: 4.035

4.  Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease.

Authors:  Naoki Kumashiro; Derek M Erion; Dongyan Zhang; Mario Kahn; Sara A Beddow; Xin Chu; Christopher D Still; Glenn S Gerhard; Xianlin Han; James Dziura; Kitt Falk Petersen; Varman T Samuel; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-19       Impact factor: 11.205

5.  Weight loss is associated with improved endothelial dysfunction via NOX2-generated oxidative stress down-regulation in patients with the metabolic syndrome.

Authors:  Francesco Angelico; Lorenzo Loffredo; Pasquale Pignatelli; Teresa Augelletti; Roberto Carnevale; Antonio Pacella; Fabiana Albanese; Ilaria Mancini; Serena Di Santo; Maria Del Ben; Francesco Violi
Journal:  Intern Emerg Med       Date:  2011-04-22       Impact factor: 3.397

6.  Personality and metabolic syndrome.

Authors:  Angelina R Sutin; Paul T Costa; Manuela Uda; Luigi Ferrucci; David Schlessinger; Antonio Terracciano
Journal:  Age (Dordr)       Date:  2010-06-22

7.  Galantamine alleviates inflammation and insulin resistance in patients with metabolic syndrome in a randomized trial.

Authors:  Fernanda M Consolim-Colombo; Carine T Sangaleti; Fernando O Costa; Tercio L Morais; Heno F Lopes; Josiane M Motta; Maria C Irigoyen; Luiz A Bortoloto; Carlos Eduardo Rochitte; Yael Tobi Harris; Sanjaya K Satapathy; Peder S Olofsson; Meredith Akerman; Sangeeta S Chavan; Meggan MacKay; Douglas P Barnaby; Martin L Lesser; Jesse Roth; Kevin J Tracey; Valentin A Pavlov
Journal:  JCI Insight       Date:  2017-07-20

8.  Comparison of coronary heart disease risk among four diagnostic definitions of metabolic syndrome.

Authors:  T Suzuki; Z Zeng; B Zhao; Z Wei; M Tanabe; T Shimbo; H Kajio; N Kato; M Naruse
Journal:  J Endocrinol Invest       Date:  2016-08-29       Impact factor: 4.256

Review 9.  The effect of exercise on the cardiovascular risk factors constituting the metabolic syndrome: a meta-analysis of controlled trials.

Authors:  Nele Pattyn; Véronique A Cornelissen; Saeed R Toghi Eshghi; Luc Vanhees
Journal:  Sports Med       Date:  2013-02       Impact factor: 11.136

10.  Concentrations of the vitamin D metabolite 1,25(OH)2D and odds of metabolic syndrome and its components.

Authors:  Jennifer W Bea; Peter W Jurutka; Elizabeth A Hibler; Peter Lance; Maria E Martínez; Denise J Roe; Christine L Sardo Molmenti; Patricia A Thompson; Elizabeth T Jacobs
Journal:  Metabolism       Date:  2014-11-29       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.